2-Methyl-2-adamantanol, min. 98%, for synthesis, 1 g, glass packaging

2,5-Dimethyl-3-hexyne-2,5-diol>99.0%(GC)25g

6-AMINO-5-(2,2-DIETHOXYETHYL)-2-MERCAPTOPYRIMIDIN-4-OL, 95.0%, 10g

2,3,4,5-Tetrahydro-1H-benzo[e][1,4]diazepin-7-ol, 97.0%, 1g

Hexa-2,4-dien-1-yl acetate, 98% (stabilizer with 0.1 alpha-tocopherol), 5g

1,3,7,9-Tetramethyl-1H-purine-2,6,8(3H,7H,9H)-trione, 99.0%, 100g

2-(3-Aminopropylamino)ethanol, 97.0%, 1g

3-PHENYL-1H-INDAZOLE, 95%, 250mg

tert-butyl 3-{[(4-chlorophenyl)methyl]amino}propanoate, 95.0%, 2g

4-Bromoquinoline-2-carboxylic acid, 95.0%, 5g

2-(2-Butyl-4-oxocyclopentyl)acetic acid, 98.0%, 250mg

4-Nitrostyrene (stabilized with TBC)>98.0%(GC)5g

N-Phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide, 95.0%, 250mg